BIOMAT Database Logo BIOMAT Database Logo

2,3,7-Trisubstituted pyrazolo[1,5-d][1,2,4]triazines: functionally selective GABAA alpha3-subtype agonists. 2006

Robert W Carling, and Michael G N Russell, and Kevin W Moore, and Andrew Mitchinson, and Alexander Guiblin, and Alison Smith, and Keith A Wafford, and George Marshall, and John R Atack, and Leslie J Street
Merck Sharp and Dohme Research Laboratories, The Neuroscience Research Centre, Terlings Park, Harlow, Essex, CM20 2QR, UK. robert.carling@virgin.net

Novel synthetic routes have been devised for the preparation of previously inaccessible 2,3,7-trisubstituted pyrazolo[1,5-d][1,2,4]triazines 2. These compounds are high affinity ligands for the GABA(A) benzodiazepine binding site and some analogues show functional selectivity for agonism at alpha3-containing receptors over alpha1-containing receptors with the lead compound being 32.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D011963 Receptors, GABA-A Cell surface proteins which bind GAMMA-AMINOBUTYRIC ACID and contain an integral membrane chloride channel. Each receptor is assembled as a pentamer from a pool of at least 19 different possible subunits. The receptors belong to a superfamily that share a common CYSTEINE loop. Benzodiazepine-Gaba Receptors,GABA-A Receptors,Receptors, Benzodiazepine,Receptors, Benzodiazepine-GABA,Receptors, Diazepam,Receptors, GABA-Benzodiazepine,Receptors, Muscimol,Benzodiazepine Receptor,Benzodiazepine Receptors,Benzodiazepine-GABA Receptor,Diazepam Receptor,Diazepam Receptors,GABA(A) Receptor,GABA-A Receptor,GABA-A Receptor alpha Subunit,GABA-A Receptor beta Subunit,GABA-A Receptor delta Subunit,GABA-A Receptor epsilon Subunit,GABA-A Receptor gamma Subunit,GABA-A Receptor rho Subunit,GABA-Benzodiazepine Receptor,GABA-Benzodiazepine Receptors,Muscimol Receptor,Muscimol Receptors,delta Subunit, GABA-A Receptor,epsilon Subunit, GABA-A Receptor,gamma-Aminobutyric Acid Subtype A Receptors,Benzodiazepine GABA Receptor,Benzodiazepine Gaba Receptors,GABA A Receptor,GABA A Receptor alpha Subunit,GABA A Receptor beta Subunit,GABA A Receptor delta Subunit,GABA A Receptor epsilon Subunit,GABA A Receptor gamma Subunit,GABA A Receptor rho Subunit,GABA A Receptors,GABA Benzodiazepine Receptor,GABA Benzodiazepine Receptors,Receptor, Benzodiazepine,Receptor, Benzodiazepine-GABA,Receptor, Diazepam,Receptor, GABA-A,Receptor, GABA-Benzodiazepine,Receptor, Muscimol,Receptors, Benzodiazepine GABA,Receptors, GABA A,Receptors, GABA Benzodiazepine,delta Subunit, GABA A Receptor,epsilon Subunit, GABA A Receptor,gamma Aminobutyric Acid Subtype A Receptors
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014227 Triazines Heterocyclic rings containing three nitrogen atoms, commonly in 1,2,4 or 1,3,5 or 2,4,6 formats. Some are used as HERBICIDES. Triazine,Benzotriazines
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Robert W Carling, and Michael G N Russell, and Kevin W Moore, and Andrew Mitchinson, and Alexander Guiblin, and Alison Smith, and Keith A Wafford, and George Marshall, and John R Atack, and Leslie J Street
Imidazo[1,2-b][1,2,4]triazines as alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxiety.
March 2006, Bioorganic & medicinal chemistry letters,
Robert W Carling, and Michael G N Russell, and Kevin W Moore, and Andrew Mitchinson, and Alexander Guiblin, and Alison Smith, and Keith A Wafford, and George Marshall, and John R Atack, and Leslie J Street
Imidazo[1,5-d][1,2,4]triazines as potential antiasthma agents.
November 1985, Journal of medicinal chemistry,
Robert W Carling, and Michael G N Russell, and Kevin W Moore, and Andrew Mitchinson, and Alexander Guiblin, and Alison Smith, and Keith A Wafford, and George Marshall, and John R Atack, and Leslie J Street
Efficient routes to pyrazolo[3,4-e][1,2,4]triazines and a new ring system: [1,2,4]triazino[5,6-d][1,2,3]triazines.
May 2010, Molecules (Basel, Switzerland),
Robert W Carling, and Michael G N Russell, and Kevin W Moore, and Andrew Mitchinson, and Alexander Guiblin, and Alison Smith, and Keith A Wafford, and George Marshall, and John R Atack, and Leslie J Street
Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.
January 2020, Medicinal chemistry (Shariqah (United Arab Emirates)),
Robert W Carling, and Michael G N Russell, and Kevin W Moore, and Andrew Mitchinson, and Alexander Guiblin, and Alison Smith, and Keith A Wafford, and George Marshall, and John R Atack, and Leslie J Street
A new class of pyrazolo[5,1-c][1,2,4]triazines as γ-aminobutyric type A (GABAA) receptor subtype ligand: synthesis and pharmacological evaluation.
May 2018, Bioorganic & medicinal chemistry,
Robert W Carling, and Michael G N Russell, and Kevin W Moore, and Andrew Mitchinson, and Alexander Guiblin, and Alison Smith, and Keith A Wafford, and George Marshall, and John R Atack, and Leslie J Street
GABAA receptor alpha2/alpha3 subtype-selective modulators as potential nonsedating anxiolytics.
January 2010, Current topics in behavioral neurosciences,
Robert W Carling, and Michael G N Russell, and Kevin W Moore, and Andrew Mitchinson, and Alexander Guiblin, and Alison Smith, and Keith A Wafford, and George Marshall, and John R Atack, and Leslie J Street
Imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4]benzodiazepines as potent and highly selective GABAA alpha5 inverse agonists with potential for the treatment of cognitive dysfunction.
October 2009, Bioorganic & medicinal chemistry letters,
Robert W Carling, and Michael G N Russell, and Kevin W Moore, and Andrew Mitchinson, and Alexander Guiblin, and Alison Smith, and Keith A Wafford, and George Marshall, and John R Atack, and Leslie J Street
Pyrimidine derivatives and related compounds. 4. A route for the synthesis of pyrazolo[3,4-e]-as-triazines, pyrazolo[3,4-d]pyrimidines, and pyrazolo[1,5-c]-as-triazines.
November 1976, The Journal of organic chemistry,
Robert W Carling, and Michael G N Russell, and Kevin W Moore, and Andrew Mitchinson, and Alexander Guiblin, and Alison Smith, and Keith A Wafford, and George Marshall, and John R Atack, and Leslie J Street
In vitro and in vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA receptor alpha5 subtype-selective inverse agonist.
November 2009, The Journal of pharmacology and experimental therapeutics,
Robert W Carling, and Michael G N Russell, and Kevin W Moore, and Andrew Mitchinson, and Alexander Guiblin, and Alison Smith, and Keith A Wafford, and George Marshall, and John R Atack, and Leslie J Street
Functionally selective dopamine D₂, D₃ receptor partial agonists.
June 2014, Journal of medicinal chemistry,
Copied contents to your clipboard!